Skip to main content

INSIGHT FOR EYESIGHT – Novel mRNA medicines for eye disease

Project description

Pioneering mRNA therapy could promote healing and reduce loss of vision

Messenger RNA (mRNA) plays a pivotal role in gene expression. During transcription, the code carried in DNA is copied to a single strand of mRNA. The mRNA is then used as a template to assemble the appropriate sequence of amino acids into the protein. INSIGHT EU has developed a proprietary mRNA-delivery platform that is already being used to treat chronic kidney disease. The project has now turned its sights to treatments for impaired vision and blindness. Development of mRNA therapies delivered to the eye could promote healing and ameliorate vision loss. Success could open a new window on life for millions with impaired vision.

Call for proposal

H2020-INNOSUP-2018-2020

See other projects for this call

Sub call

H2020-INNOSUP-2019-02

Coordinator

MERCURNA BV
Net EU contribution
€ 75 937,50
Address
Geurdeland 17g
6673 DR Andelst
Netherlands

See on map

Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00